The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
legal
Corporate Boutique Law Firm Nemphos Braue Adds Two to Legal Team
Continuing to diversify its breadth and depth of legal talent and expertise, Nemphos Braue LLC welcomes Katelynn M. Brennan and Caroline Popper.
FTC Ban on Noncompetes Struck Down by Federal Judge
The ban issued in April had been set to go into effect September 4th. The ruling is effective nationwide.
Nemphos Braue Adds Three to the Team
With a focus on providing boutique-style service to its corporate and business law clients, Nemphos Braue has added three additional team members to support the firm’s continued growth.
Update Regarding the Corporate Transparency Act
A Federal District Court Judge in Alabama has ruled the CTA “unconstitutional” – what does that mean for businesses?
Nemphos Braue to Host Event at Baltimore Innovation Week
The workshop titled “Helping Founders Flourish and Raise Millions” will feature multiple speakers including George Nemphos.
Latest Insights
View All
CTA Update: New Deadline Now in Effect
BOI reporting requirements under the CTA are back in effect. The new deadline for most reporting companies is now March 21, 2025.
Trade Secrets and MedTech: IP in the News
The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
MedTech M&A is Poised for Growth
In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
